Logo image of EMAN

EMAGIN CORPORATION (EMAN) Stock Fundamental Analysis

NYSEARCA:EMAN - NYSE Arca - US29076N2062 - Common Stock - Currency: USD

2.07  +0.06 (+2.99%)

After market: 2.07 0 (0%)

Fundamental Rating

1

Taking everything into account, EMAN scores 1 out of 10 in our fundamental rating. EMAN was compared to 110 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and financial health of EMAN have multiple concerns. EMAN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year EMAN has reported negative net income.
In the past year EMAN has reported a negative cash flow from operations.
EMAN had negative earnings in each of the past 5 years.
In the past 5 years EMAN always reported negative operating cash flow.
EMAN Yearly Net Income VS EBIT VS OCF VS FCFEMAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 -5M -10M -15M -20M

1.2 Ratios

EMAN has a Return On Assets of -18.20%. This is amonst the worse of the industry: EMAN underperforms 83.02% of its industry peers.
The Return On Equity of EMAN (-114.25%) is worse than 88.68% of its industry peers.
Industry RankSector Rank
ROA -18.2%
ROE -114.25%
ROIC N/A
ROA(3y)-11.89%
ROA(5y)-17.55%
ROE(3y)-34.55%
ROE(5y)-36.21%
ROIC(3y)N/A
ROIC(5y)N/A
EMAN Yearly ROA, ROE, ROICEMAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 -20 -40 -60

1.3 Margins

Looking at the Gross Margin, with a value of 26.24%, EMAN is doing worse than 80.19% of the companies in the same industry.
In the last couple of years the Gross Margin of EMAN has grown nicely.
EMAN does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.34%
GM growth 5Y7.77%
EMAN Yearly Profit, Operating, Gross MarginsEMAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 20 -20

More info and screens

2

2. Health

2.1 Basic Checks

EMAN does not have a ROIC to compare to the WACC, probably because it is not profitable.
EMAN has more shares outstanding than it did 1 year ago.
EMAN has a better debt/assets ratio than last year.
EMAN Yearly Shares OutstandingEMAN Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M 80M
EMAN Yearly Total Debt VS Total AssetsEMAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M

2.2 Solvency

EMAN has an Altman-Z score of -3.59. This is a bad value and indicates that EMAN is not financially healthy and even has some risk of bankruptcy.
EMAN has a Altman-Z score of -3.59. This is amonst the worse of the industry: EMAN underperforms 81.13% of its industry peers.
A Debt/Equity ratio of 1.59 is on the high side and indicates that EMAN has dependencies on debt financing.
EMAN has a Debt to Equity ratio of 1.59. This is amonst the worse of the industry: EMAN underperforms 87.74% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.59
Debt/FCF N/A
Altman-Z -3.59
ROIC/WACCN/A
WACC12.71%
EMAN Yearly LT Debt VS Equity VS FCFEMAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 10M -10M 20M -20M

2.3 Liquidity

A Current Ratio of 2.06 indicates that EMAN has no problem at all paying its short term obligations.
EMAN has a worse Current ratio (2.06) than 75.47% of its industry peers.
A Quick Ratio of 1.16 indicates that EMAN should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.16, EMAN is doing worse than 81.13% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.06
Quick Ratio 1.16
EMAN Yearly Current Assets VS Current LiabilitesEMAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 5M 10M 15M 20M 25M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for EMAN have decreased strongly by -650.00% in the last year.
The Revenue has been growing slightly by 0.19% in the past year.
The Revenue has been growing slightly by 6.74% on average over the past years.
EPS 1Y (TTM)-650%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-550%
Revenue 1Y (TTM)0.19%
Revenue growth 3Y4.54%
Revenue growth 5Y6.74%
Sales Q2Q%-30.79%

3.2 Future

The Earnings Per Share is expected to decrease by -177.41% on average over the next years. This is quite bad
Based on estimates for the next years, EMAN will show a small growth in Revenue. The Revenue will grow by 2.91% on average per year.
EPS Next Y-1648.97%
EPS Next 2Y-177.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-25.5%
Revenue Next 2Y2.91%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
EMAN Yearly Revenue VS EstimatesEMAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
EMAN Yearly EPS VS EstimatesEMAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2023 2024 -0.05 -0.1 -0.15 -0.2 -0.25

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EMAN. In the last year negative earnings were reported.
Also next year EMAN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
EMAN Price Earnings VS Forward Price EarningsEMAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EMAN Per share dataEMAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2

4.3 Compensation for Growth

A cheap valuation may be justified as EMAN's earnings are expected to decrease with -177.41% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-177.41%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

EMAN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EMAGIN CORPORATION

NYSEARCA:EMAN (10/17/2023, 8:04:00 PM)

After market: 2.07 0 (0%)

2.07

+0.06 (+2.99%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)08-10 2023-08-10/bmo
Earnings (Next)11-08 2023-11-08/bmo
Inst Owners0.75%
Inst Owner Change0%
Ins Owners0.12%
Ins Owner Change0%
Market Cap172.20M
Analysts82.5
Price Target3.06 (47.83%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-210.46%
Min EPS beat(2)-324.84%
Max EPS beat(2)-96.08%
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-22.35%
Min Revenue beat(2)-30.23%
Max Revenue beat(2)-14.46%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-60%
EPS NY rev (1m)0%
EPS NY rev (3m)-138.09%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-33.44%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-24.84%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 6.25
P/FCF N/A
P/OCF N/A
P/B 14.77
P/tB 14.81
EV/EBITDA N/A
EPS(TTM)-0.15
EYN/A
EPS(NY)-0.11
Fwd EYN/A
FCF(TTM)-0.27
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0.33
BVpS0.14
TBVpS0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.2%
ROE -114.25%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.24%
FCFM N/A
ROA(3y)-11.89%
ROA(5y)-17.55%
ROE(3y)-34.55%
ROE(5y)-36.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y10.34%
GM growth 5Y7.77%
F-Score2
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 1.59
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 583.49%
Cap/Sales 56.54%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.06
Quick Ratio 1.16
Altman-Z -3.59
F-Score2
WACC12.71%
ROIC/WACCN/A
Cap/Depr(3y)406.79%
Cap/Depr(5y)278.01%
Cap/Sales(3y)39.01%
Cap/Sales(5y)25.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-650%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-550%
EPS Next Y-1648.97%
EPS Next 2Y-177.41%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.19%
Revenue growth 3Y4.54%
Revenue growth 5Y6.74%
Sales Q2Q%-30.79%
Revenue Next Year-25.5%
Revenue Next 2Y2.91%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-69.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year84.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-196.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-4.32%
OCF growth 3YN/A
OCF growth 5YN/A